AI assistant
SUTRO BIOPHARMA, INC. — Director's Dealing 2021
Aug 11, 2021
34319_dirs_2021-08-11_92c79937-43ce-4d46-a4df-22f7017c53cf.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: SUTRO BIOPHARMA, INC. (STRO)
CIK: 0001382101
Period of Report: 2021-08-09
Reporting Person: Chung Jane (Chief Commercial Officer)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-08-09 | Stock Option (right to buy) | $18.37 | A | 160000 | Acquired | 2031-08-08 | Common Stock (160000) | Direct |
| 2021-08-09 | Restricted Stock Unit (RSU) | $ | A | 75000 | Acquired | 2025-08-09 | Common Stock (75000) | Direct |
Footnotes
F1: The option vests as to 1/4th of the total shares on August 9, 2022 and then 1/48th of the total shares vest monthly thereafter, with 100% of the total shares vested and exercisable on August 9, 2025, subject to the reporting person's provision of service to the issuer on each vesting date.
F2: Each RSU represents a contingent right to receive one (1) share of the issuer's Common Stock upon settlement.
F3: The RSUs vest as to 1/4th of the total shares annually beginning on August 9, 2022, subject to the reporting person's provision of service to the issuer on each vesting date.